ONCONETIX, INC.

201 E. Fifth Street, Suite 1900

Cincinnati, OH

 

December 11, 2024

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, DC 20549

 

Re:	Onconetix, Inc.
	Registration Statement on Form S-1
	File No. 333-282958

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:00 p.m. EST on Thursday, December 12, 2024, or as soon as practicable thereafter.

 

	Very truly yours,
	/s/ Karina M. Fedasz
	Karina M. Fedasz
	Interim Chief Financial Officer

 

cc:   Ellenoff Grossman & Schole LLP